The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.

Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...

The pulmonary function test (PFT) alone may be inadequate for predicting work-related exercise capacity in patients who file workers' compensation claims for respiratory limitation and compensation.